Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Half Year Trading Update

30 Sep 2013 07:00

RNS Number : 1662P
Science in Sport PLC
30 September 2013
 



For immediate release

30 September 2013

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

Half Year Trading Update

Science in Sport plc (AIM: SIS), a leading sports nutrition company, is pleased to announce the following pre-close trading update ahead of its financial results for the half year ended 30 September 2013.

The Board is pleased to report another period of significant revenue growth with sales expected to be up 23 per cent, compared with the same period last year, at approximately £3.95 million.

Revenue growth in the half year has been driven by strong sales of isotonic gels, food bars and hydration tablets and reflects the Company's on-going investment in product innovation, sales and marketing.

The revenue growth highlights the strength of the SiS brand and the resilience of the sports nutrition category. The growth was evident in all channels including major grocers, high street outlets, independent retailers and e-commerce, as well as in international markets.

Pre-tax profits for the half year are expected to be in line with management expectations and the Board remains confident of the outlook for continued revenue growth in the full year.

Science in Sport intends to issue its half year results in early December 2013.

 

For further information:

Science in Sport PLC

+44 (0) 1753 861722

Stephen Moon, CEO

Cenkos Securities

+44 (0) 20 7397 8900

Bobbie Hilliam - NOMAD and Broker

Buchanan

+44 (0) 20 7466 5000

Mark Court / Sophie McNulty / Fiona Henson

sis@buchanan.uk.com

 

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2012 London Olympics, 24 medal-winning athletes or teams used SiS products.

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars and hydration tablets; and SiS REGO, including protein-based recovery powders and bars. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

SiS is currently the official sports nutrition supplier to cycling teams Rapha Condor JLT, Belkin Pro Cycling, Madison Genesis, Pro Team Astana and Team Katusha. SiS is also currently the official supplier of sports drinks and sports nutrition to the GB Rowing Team. Mark Cavendish, the Manx Missile, is an elite sports consultant and Olympians Sir Chris Hoy, Helen Jenkins and Rebecca Romero are official brand ambassadors.

SiS was founded in 1992 and is headquartered in Windsor, Berkshire. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVEAFIDFIV
Date   Source Headline
27th Jul 201812:13 pmRNSHolding(s) in Company
19th Jul 20187:00 amRNSHalf Year Trading Update
27th Jun 20187:00 amRNSSIS SPORTS DRINK FUELS GIRO D'ITALIA SUCCESS
19th Jun 20185:00 pmRNSResult of AGM
12th Jun 201812:30 pmRNSDirector/PDMR Shareholding
6th Jun 20184:30 pmRNSDirector/PDMR Shareholding
6th Jun 20187:00 amRNSPosting of AR&A and Notice of AGM
6th Jun 20187:00 amRNSHolding(s) in Company
6th Jun 20187:00 amRNSHolding(s) in Company
4th Jun 201812:00 pmRNSHolding(s) in Company
31st May 201811:00 amRNSPDMR Dealing
29th May 20187:00 amRNSHolding(s) in Company
21st May 20184:21 pmRNSDirector/PDMR Shareholding
14th May 20183:15 pmRNSHolding(s) in Company
4th May 20189:45 amRNSIssue of Equity and Total Voting Rights
16th Apr 20184:57 pmRNSDirector/PDMR Shareholding
13th Apr 20184:32 pmRNSPDMR Dealings - Exercise of Options
22nd Mar 20183:57 pmRNSHolding(s) in Company
22nd Mar 20187:00 amRNSPDMR Dealings Grant of Options
22nd Mar 20187:00 amRNSIssue of Equity
21st Mar 20187:00 amRNSOlympic Champion Adam Peaty Becomes SIS Ambassador
21st Mar 20187:00 amRNSFinal Results
14th Feb 201810:49 amRNSHolding(s) in Company
9th Feb 20183:17 pmRNSHolding(s) in Company
9th Feb 20183:16 pmRNSHolding(s) in Company
8th Feb 20183:37 pmRNSHolding(s) in Company
18th Jan 20184:41 pmRNSIssue of Equity
18th Jan 20187:00 amRNSSiS becomes Official Partner of Manchester United
17th Jan 20183:44 pmRNSHolding(s) in Company
16th Jan 20187:00 amRNSPre-Close Trading Update
6th Dec 20174:47 pmRNSHolding(s) in Company
6th Dec 201710:29 amRNSHolding(s) in Company
6th Dec 201710:27 amRNSHolding(s) in Company
6th Dec 201710:20 amRNSHolding(s) in Company
5th Dec 20177:00 amRNSHolding(s) in Company
4th Dec 20171:22 pmRNSDirector/PDMR Shareholding
1st Dec 201712:44 pmRNSResults of General Meeting and Open Offer
14th Nov 20177:00 amRNSFirm Placing and Open Offer
27th Oct 20177:00 amRNSSiS announces three-year deal with USA Triathlon
27th Oct 20177:00 amRNSSiS announces partnership with Rock 'n' Roll
20th Sep 20179:06 amRNSHalf-year Report - Replacement
20th Sep 20177:00 amRNSHalf-year Report
12th Sep 20172:43 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSTHREE MORE YEARS FOR SiS AND TEAM SKY
4th Aug 20177:00 amRNSSIS to fuel leading British football clubs
3rd Aug 20177:00 amRNSNotice of Results
20th Jul 20177:00 amRNSHalf Year Trading Update
26th Jun 20174:30 pmEQSCavendish Asset Management: Paul Mumford named Small Cap Awards' Fund Manager of the Year
26th Jun 201712:29 pmRNSDirector/PDMR Shareholding
21st Jun 201712:44 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.